Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.

Authors:
van Groesen E; Innocenti P; Martin NI.

Journal:
ACS Infect Dis

Publication Year: 2022

DOI:
10.1021/acsinfecdis.2c00253

PMCID:
PMC9379927

PMID:
35895325

View on PubMed View on PMC View Publisher
Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Chelation of Mitochondrial Iron as an Antiparasitic Strategy.
Arbon D; Mach J; Čadková A and 10 more (2024) - Transparency Score: 3/6
Enhanced Antimalarial and Antisequestration Activity of Methoxybenzenesulfonate-Modified Biopolymer…
Najer A; Kim J; Saunders C and 3 more (2024) - Transparency Score: 3/6
Extracellular Vesicles in Malaria: Shedding Light on Pathogenic Depths.
Dey S; Mohapatra S; Khokhar M and 2 more (2024) - Transparency Score: 2/6
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Mot…
Hauser BM; Sangesland M; Lam EC and 10 more (2024) - Transparency Score: 3/6
High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of <i>Plasm…
Johannsen S; Gierse RM; Krüger A and 23 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare no competing financial interest."

Evidence found in paper:

"Financial support provided by the European Research Council (ERC consolidator grant to N.I.M., grant agreement no. 725523)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025